GSTM1 and anemia (phenotype): From D0 to last observation, 82.7% of the patients had at least one Hb measurement fulfilling the anaemia criteria (any grade of severity), corresponding to 26,408 (67.9%) of the total 38,864 Hb measurements; of these, 20,430 (77.4%) occurred after treatment start (D1-D28).